L. H. Undset

Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients – a three‐yr serial echocardiographic substudy of the randomized controlled CENTRAL trial

H. Holdaas, S. Aakhus, K. Midtvedt, 2015, Clinical transplantation.

Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

H. Fagertun, H. Holdaas, S. Sørensen, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation

T. Jenssen, T. Hovig, A. Heiberg, 2010, NDT plus.

Computer-Assisted Cyclosporine Dosing Performs Better Than Traditional Dosing in Renal Transplant Recipients: Results of a Pilot Study

A. Åsberg, A. Hartmann, H. Holdaas, 2010, Therapeutic drug monitoring.

Cardiac Response to Early Conversion from Calcineurin Inhibitor to Everolimus in Renal Transplant Recipients: An Echocardiographic Substudy of the Randomized Controlled CENTRAL Trial

H. Holdaas, S. Aakhus, R. Massey, 2014, Transplantation.

Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

H. Fagertun, H. Holdaas, S. Sørensen, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.